Wnt family ligands

EMT inhibitor-1 is an inhibitor of of Hippo , TGF-β , and Wnt signaling pathways with antitumor activities.In VitroEMT inhibitor-1 (C19) (0-10μM 24 hours) is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities,

Endothelin-1 (1-31) (Human) TFA is a potent vasoconstrictor and hypertensive agent. Endothelin-1 (1-31) (Human) TFA is derived from the selective hydrolysis of big ET-1 by chymase.Appearance:SolidIn Vitro:Endothelin-1 (1-31) (Human) (100 pM-100 nM

Endothelin-1 (1-31) (Human) TFA is a potent vasoconstrictor and hypertensive agent. Endothelin-1 (1-31) (Human) TFA is derived from the selective hydrolysis of big ET-1 by chymase.Appearance:SolidIn Vitro:Endothelin-1 (1-31) (Human) (100 pM-100 nM

Endothelin-1 (1-31) (Human) TFA is a potent vasoconstrictor and hypertensive agent. Endothelin-1 (1-31) (Human) TFA is derived from the selective hydrolysis of big ET-1 by chymase.Appearance:SolidIn Vitro:Endothelin-1 (1-31) (Human) (100 pM-100 nM

ENMD-1198 (IRC-110160), an orally active microtubule destabilizing agent, is a 2-methoxyestradiol analogue with antiproliferative and antiangiogenic activity. ENMD-1198 is suitable for inhibiting HIF-1alpha and STAT3 in human HCC cells and leads to

ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1 / 2 inhibitor, showing 60% inhibition at 1 nM and an IC 50 of 3.0 nM against ERK1 and ERK2 , respectivelyIn VitroERK1/2 inhibitor 1 (Compound 27) shows excellent antiproliferative potency with

ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1 / 2 inhibitor, showing 60% inhibition at 1 nM and an IC 50 of 3.0 nM against ERK1 and ERK2 , respectivelyIn VitroERK1/2 inhibitor 1 (Compound 27) shows excellent antiproliferative potency with

ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1 / 2 inhibitor, showing 60% inhibition at 1 nM and an IC 50 of 3.0 nM against ERK1 and ERK2 , respectivelyIn VitroERK1/2 inhibitor 1 (Compound 27) shows excellent antiproliferative potency with

ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1 / 2 inhibitor, showing 60% inhibition at 1 nM and an IC 50 of 3.0 nM against ERK1 and ERK2 , respectivelyIn VitroERK1/2 inhibitor 1 (Compound 27) shows excellent antiproliferative potency with

ERK1/2 inhibitor 1 is a potent, orally bioavailable ERK1 / 2 inhibitor, showing 60% inhibition at 1 nM and an IC 50 of 3.0 nM against ERK1 and ERK2 , respectivelyIn VitroERK1/2 inhibitor 1 (Compound 27) shows excellent antiproliferative potency with

ERK1/2 inhibitor 7 is a potent ERK inhibitor with an IC 50 of 0.94 nM for ERK2 (WO2021110168A1, WX006).Form:Solid

ERK1/2 inhibitor 7 is a potent ERK inhibitor with an IC 50 of 0.94 nM for ERK2 (WO2021110168A1, WX006).Form:Solid